Business, Economics, And Law Of Genomic Biology

  • Research
  • People
  • In The News
  • Publications
The Business, Economics, and Law of Genomic Biology

What is the nature of innovation in genomics and how might the genomics-related industries evolve? What are the roles of university-based start-up companies, independent start-ups, corporate spin-offs, and established firms, within these industries? How can genomics-related products become viable alternatives to existing products based on chemicals and other industries? How can we design intellectual property regimes that maximize total social welfare? What business strategies are most effective for protecting and appropriating value from innovation, including intellectual property rights? As genomics expertise evolves internationally, how does this affect the creation and use of genomics in the U.S.? In high-technology environments such as genomic biology, navigating business, legal, and economic issues like these are as important for scientist-led firms as the innovations themselves.